Gambia vs India: New cases tested for RR-/MDR-TB
Gambia
92.0%
in 2024
India
92.0%
in 2024
Gambia rank
87th
India rank
87th
New cases tested for RR-/MDR-TB over time
- Gambia
- India
How they compare
Gambia currently reports 92.0% against 92.0% in India, a difference of 0.0%.
The two have swapped places 6 times across 12 shared years of data; in 2007 it was India ahead.
Gambia ranks 87th and India ranks 87th of 192 countries.
India has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 20.0% | 37.5% | 17.5% | India |
| 2020s | 63.6% | 84.8% | 21.2% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Gambia or India?
- Gambia, at 92.0% against 92.0% in India as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Gambia and India?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and India?
- 12 years are reported by both, from 2007 to 2024.
- How do Gambia and India rank globally for new cases tested for rr-/mdr-tb?
- Gambia ranks 87th and India ranks 87th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.